2008
DOI: 10.1038/eye.2008.385
|View full text |Cite
|
Sign up to set email alerts
|

Current and future prospects for optoelectronic retinal prostheses

Abstract: There has been accelerating progress in the development of retinal prosthesis systems designed to partially restore vision to people with retinitis pigmentosa or macular degeneration. Current retinal prostheses can be divided into two types: those that receive power and information from passive or active photodiodes (optoelectronic systems) and those based on multielectrode arrays powered by cables or transcutaneous telemetry systems. Currently, four research groups have ongoing chronic implantation clinical s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
35
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(36 citation statements)
references
References 44 publications
0
35
0
Order By: Relevance
“…(3) For functional validity, it is important that contrast sensitivity be tested under different conditions: for example, under day and night illumination, with and without glare (Abrahamsson & Sjöstrand, 1986). (4) For prospective vision therapeutics that will eventually treat focal retinal damage with stem cells (Bull, Johnson, & Martin, 2008; Kelley et al, 2008) or neural prosthetics (Colby, Chang, Stulting, & Lane, 2007; Dowling, 2008; Weiland, Liu, & Humayun, 2005), it will be critical to measure the progression or remediation of contrast sensitivity at isolated retinal loci. Current cards and charts are not flexible enough to adequately capture the range of normal and abnormal CSFs observed across different illumination and glare conditions, temporal frequencies, and retinal loci.…”
Section: Introductionmentioning
confidence: 99%
“…(3) For functional validity, it is important that contrast sensitivity be tested under different conditions: for example, under day and night illumination, with and without glare (Abrahamsson & Sjöstrand, 1986). (4) For prospective vision therapeutics that will eventually treat focal retinal damage with stem cells (Bull, Johnson, & Martin, 2008; Kelley et al, 2008) or neural prosthetics (Colby, Chang, Stulting, & Lane, 2007; Dowling, 2008; Weiland, Liu, & Humayun, 2005), it will be critical to measure the progression or remediation of contrast sensitivity at isolated retinal loci. Current cards and charts are not flexible enough to adequately capture the range of normal and abnormal CSFs observed across different illumination and glare conditions, temporal frequencies, and retinal loci.…”
Section: Introductionmentioning
confidence: 99%
“…The current pulses are interpreted as vision by the visual cortex. Placing the implant in the subretinal space (as compared to epiretinal) allows for utilization of the existing image-processing and data-compression functions of the inner nuclear layer [3]. Working at λ = 900 nm prevents confusion by preventing stimulation of the remaining functional photoreceptor cells.…”
Section: Motivation and Approachmentioning
confidence: 99%
“…bipolar and amacrine cells). Both sub-retinal and epi-retinal approaches have been shown to be capable of generating phosphene percepts 11,12,13 . However, functional vision with these approaches is some way off.…”
Section: Introductionmentioning
confidence: 99%